Medical News

Surgery

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

O'Leary JG et al. – A short course of conivaptan increases serum sodium in patients with end–stage liver disease and may reduce the risk of proceeding to liver transplantation. Further study in a prospective clinical trial is needed to confirm safety and efficacy.

Related Articles

Recognizing and treating cutaneous signs of liver disease
Cleveland Clinic Journal of Medicine, 10/05/09    Relevance Score: 71%

Drinking Coffee Slows Progression Of Liver Disease In Chronic Hepatitis C Sufferers
ScienceDaily, 10/26/09    Relevance Score: 70%

Drinking coffee slows progression of liver disease in chronic hepatitis C sufferers
EurekAlert, 10/21/09    Relevance Score: 70%

Statin therapy initiated in a man with hepatitis C and elevated cholesterol
The Clinical Advisor, 10/07/09    Relevance Score: 70%

Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557
Antimicrobial Agents and Chemotherapy, 11/05/09    Relevance Score: 69%

Today in Transplantation...keeping you current

Post-transplant lymphoproliferative disorder localized in the colon after liver transplantation: Report of a case
Surgery Today, 12/18/09

Survival impact of lung transplantation for chronic obstructive pulmonary disease
European Respiratory Journal , 12/17/09

Effect of Liver Transplantation on Spleen Size, Collateral Veins, and Platelet Counts
World Journal of Surgery, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address